Lash Serums Are Being Marketed Like Skincare, and the Formulas Are Following Suit

Lash serums used to be a fairly narrow category: a handful of prostaglandin-analog formulas known for strong results but real side-effect risk, and a wider field of peptide serums with gentler but less dramatic effects. The newest formulas are borrowing skincare's ingredient vocabulary wholesale, adding ceramides, hyaluronic acid, and barrier language to lash line marketing.

The rationale makes some biological sense — the skin along the lash line is thin and can be irritated by daily makeup application and removal, and a serum treating that skin as skin, not just as a lash-growth delivery mechanism, addresses a real secondary problem.

It's also a marketing evolution that mirrors what's happened with scalp care: taking an area of the body historically treated as separate from "skin" and reformulating around it with the same actives and language that facial skincare has spent years establishing credibility with.

Whether the added ceramides meaningfully improve lash growth outcomes is unclear, but as an approach to reducing irritation from daily lash-serum use, it's a reasonable one.